Mustang Bio, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 5.19 million compared to USD 16.69 million a year ago. Basic loss per share from continuing operations was USD 0.46 compared to USD 2.06 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.13 USD | -3.99% | -12.46% | -90.37% |
15/05 | Mustang Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02/05 | Mustang Bio, Inc. announced that it has received $3.3 million in funding | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-90.37% | 3.66M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- MBIO Stock
- News Mustang Bio, Inc.
- Mustang Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024